Sino Biopharma Secures Approval for Anqixin from China’s National Medical Products Administration
| | | | | | |

Sino Biopharma Secures Approval for Anqixin from China’s National Medical Products Administration

Sino Biopharmaceutical Secures Approval for Innovative Hemophilia Treatment Sino Biopharmaceutical Limited, a leader in the development of innovative therapeutic solutions, has achieved a…

Tribute Rock Icon Swan Montgomery’s Biography Officially Launches Today “Zepagain: Led By Zeppelin, In Tribute by Swan Montgomery” Now Available Worldwide

Tribute Rock Icon Swan Montgomery’s Biography Officially Launches Today “Zepagain: Led By Zeppelin, In Tribute by Swan Montgomery” Now Available Worldwide

PRWire

BREAKING: Tribute Rock Icon Swan Montgomery’s Biography Officially Launches Today “Zepagain: Led By Zeppelin, In Tribute by Swan Montgomery” Now…

PRWire Press release Distribution Service.

| |

Buybacks of shares by H&M during week 26, 2025

Between 26 June 2025 and 27 June 2025 H & M Hennes & Mauritz AB (publ) (LEI code 529900O5RR7R39FRDM42) has repurchased in total 137,500 of the company’s own class B shares (ISIN: SE0000106270) as part of the share buyback programme initiated by the board of directors to secure delivery of class B shares for the company’s long-term incentive program (LTIP).

The share buybacks form part of the around SEK 175 million share buyback programme that H&M announced on 26 June 2025. The programme aims to secure delivery of class B shares to the participants in the company’s long-term incentive

| |

H&M decides to buy back own shares for the company’s long-term incentive program (LTIP)

The board of directors of H & M Hennes & Mauritz AB has, on the basis of the authorisation granted by the 2025 annual general meeting, decided to acquire the company’s own class B shares in order to ensure the delivery of class B shares to the participants in the company’s long-term incentive program (LTIP).

The share buybacks will be carried out in accordance with the EU Market Abuse Regulation (MAR) and Commission Delegated Regulation (EU) 2016/1052 (known as the Safe Harbour Regulation). Acquisitions of shares will be managed by an investment firm or credit institution that makes its

| | | | | | | |

H & M Hennes & Mauritz AB Six-month report 2025

Second quarter (1 March 2025 – 31 May 2025)

· Sales in local currencies increased by 1 percent in the second quarter, with 4 percent fewer stores at the end of the quarter compared with the same point in time last year. Excluding these closures, sales increased by 3 percent. Converted into SEK, net sales amounted to SEK 56,714 m (59,605). Net sales in SEK were negatively affected by a currency translation effect of around 6 percentage points due to the strengthened Swedish krona.
· Gross profit amounted to SEK 31,425 m (33,569), which corresponds to a gross margin of 55.4 percent (

| | | | | | | |

H & M Hennes & Mauritz AB Six-month report 2025

Second quarter (1 March 2025 – 31 May 2025)

· Sales in local currencies increased by 1 percent in the second quarter, with 4 percent fewer stores at the end of the quarter compared with the same point in time last year. Excluding these closures, sales increased by 3 percent. Converted into SEK, net sales amounted to SEK 56,714 m (59,605). Net sales in SEK were negatively affected by a currency translation effect of around 6 percentage points due to the strengthened Swedish krona.
· Gross profit amounted to SEK 31,425 m (33,569), which corresponds to a gross margin of 55.4 percent (